Paper795537
Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity.
Weiss AJ and 5 others. Cancer Treat Rep, 1976. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. Papers, record 795537. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/795537
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Heart Diseases | Major topic |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Leukopenia | |
| Male | |
| Middle Aged | |
| Nausea | |
| Neoplasms | |
| Prognosis | |
| Stomatitis | |
| Thrombocytopenia |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37383708 | Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37383708 | PubMed |
| 33404976 | Multiscale and Translational Quantitative Systems Toxicology, Pharmacokinetic-Toxicodynamic Modeling Analysis for Assessment of Doxorubicin-Induced Cardiotoxicity. | AAPS J | 2021 | https://conductscience.org/library/papers/33404976 | PubMed |
| 23166343 | Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. | Pediatrics | 2012 | https://conductscience.org/library/papers/23166343 | PubMed |
| 21737575 | Cardiovascular complications of breast cancer therapy in older adults. | Oncologist | 2011 | https://conductscience.org/library/papers/21737575 | PubMed |
| 16808550 | Heart failure induced by non-cardiac drugs. | Drug Saf | 2006 | https://conductscience.org/library/papers/16808550 | PubMed |
| 15977964 | Cardiotoxicity of cancer chemotherapy: implications for children. | Paediatr Drugs | 2005 | https://conductscience.org/library/papers/15977964 | PubMed |
| 10789823 | Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. | Drug Saf | 2000 | https://conductscience.org/library/papers/10789823 | PubMed |
| 8968695 | A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy. | Drug Saf | 1996 | https://conductscience.org/library/papers/8968695 | PubMed |
| 8280512 | Anthracyclines and the heart. | Br Heart J | 1993 | https://conductscience.org/library/papers/8280512 | PubMed |
| 7340990 | Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7340990 | PubMed |
| 6961377 | Anthracycline cardiomyopathy. | Pediatr Cardiol | 1982 | https://conductscience.org/library/papers/6961377 | PubMed |
| 6590531 | Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic study. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6590531 | PubMed |
| 6574828 | A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6574828 | PubMed |
| 4058077 | Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours. | Med Oncol Tumor Pharmacother | 1985 | https://conductscience.org/library/papers/4058077 | PubMed |
| 4052636 | Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment. | Breast Cancer Res Treat | 1985 | https://conductscience.org/library/papers/4052636 | PubMed |
| 3987800 | Pharmacokinetic study of i.v. infusions of adriamycin. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3987800 | PubMed |
| 3888428 | Anticancer drug pharmacodynamics. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3888428 | PubMed |
| 3555940 | Pharmacokinetics of anticancer drugs in children. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3555940 | PubMed |
| 3520474 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3520474 | PubMed |
| 3463436 | Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3463436 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/795537
GET https://conductscience.org/api/papers/v1/795537/cited_by?page=2